2021, Volume 14, Issue 1, pp 17 – 20

The role of novel poly (ADP-ribose) inhibitors in the treatment of locally advanced and metastatic Her-2/neu negative breast cancer with inherited germline BRCA1/2 mutations. A review of the literature

Issues

Special Issues